MEDEX – OP: Advancing The Management Of Osteoporosis.

*BONE BLOGS: MEDEX – OP: Advancing The Management Of Osteoporosis. 

We were delighted that Channel 7 recently visited The Bone Clinic to find out about the novel MEDEX – OP trial being run by Griffith PhD student, Melanie Fischbacher and TBC Director Professor Belinda Beck.

One in three women over the age of 50 will experience an osteoporotic fracture and suffer adverse consequences such as chronic pain, loss of independence, or social isolation. The MEDEX-OP trial hopes to shine some light on how bone medication influences the efficacy of bone-targeted exercise training.  

Both medication and bone-targeted exercise have been shown to increase bone density and decrease fracture risk, but they work in different ways. It is not yet known whether those treatments work better in combination.

The MEDEX-OP trial is also comparing the efficacy of two different exercise programs that have been designed for people with low bone mass. 

Postmenopausal women who are currently taking bone medication such as Fosamax, Actonel, Aclasta or Prolia are still needed for the MEDEX- OP trial. The study involves 
8-months of a free, twice-weekly exercise program conducted at The Bone Clinic in Coorparoo, Brisbane.

To find out more about the MEDEX – OP trial please contact Melanie at or visit the website